Conditional approval for Hansa’s kidney transplant drug by Selina McKee | Aug 27, 2020 | News | 0 Idefirix is an immunosuppressant that reduces the level of donor specific antibodies, thus enabling transplantation Read More
Novartis’ iscalimab results hint at extended survival of transplanted organs by Anna Smith | Jun 10, 2019 | News | 0 Currently the average life-span of a transplanted kidney is 12 years for a deceased donor kidney, and about 15 years for a living related transplant. Read More